| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 3 |
| NetGPI | no | yes: 0, no: 3 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 3 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9B5I9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.601 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.533 |
| DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.491 |
| DOC_WW_Pin1_4 | 70 | 75 | PF00397 | 0.608 |
| DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.258 |
| LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.491 |
| LIG_CaM_NSCaTE_8 | 80 | 87 | PF13499 | 0.483 |
| LIG_FHA_1 | 40 | 46 | PF00498 | 0.443 |
| LIG_FHA_2 | 15 | 21 | PF00498 | 0.548 |
| LIG_LIR_Gen_1 | 77 | 88 | PF02991 | 0.608 |
| LIG_LIR_Nem_3 | 77 | 83 | PF02991 | 0.562 |
| LIG_LIR_Nem_3 | 8 | 12 | PF02991 | 0.548 |
| LIG_Pex14_2 | 50 | 54 | PF04695 | 0.491 |
| LIG_REV1ctd_RIR_1 | 104 | 110 | PF16727 | 0.408 |
| LIG_SH2_CRK | 41 | 45 | PF00017 | 0.491 |
| LIG_SH2_STAP1 | 12 | 16 | PF00017 | 0.547 |
| LIG_SH2_STAP1 | 41 | 45 | PF00017 | 0.491 |
| LIG_SH2_STAT5 | 2 | 5 | PF00017 | 0.524 |
| LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.491 |
| LIG_SUMO_SIM_par_1 | 42 | 47 | PF11976 | 0.491 |
| LIG_TYR_ITIM | 39 | 44 | PF00017 | 0.491 |
| MOD_CK1_1 | 86 | 92 | PF00069 | 0.331 |
| MOD_CK2_1 | 14 | 20 | PF00069 | 0.437 |
| MOD_CK2_1 | 2 | 8 | PF00069 | 0.533 |
| MOD_CMANNOS | 101 | 104 | PF00535 | 0.491 |
| MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.316 |
| MOD_GSK3_1 | 14 | 21 | PF00069 | 0.531 |
| MOD_GSK3_1 | 40 | 47 | PF00069 | 0.491 |
| MOD_GSK3_1 | 70 | 77 | PF00069 | 0.608 |
| MOD_N-GLC_2 | 57 | 59 | PF02516 | 0.491 |
| MOD_NEK2_1 | 39 | 44 | PF00069 | 0.427 |
| MOD_Plk_4 | 40 | 46 | PF00069 | 0.372 |
| MOD_Plk_4 | 97 | 103 | PF00069 | 0.491 |
| MOD_ProDKin_1 | 70 | 76 | PF00069 | 0.608 |
| MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.258 |
| TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.491 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3S7X8M1 | Leishmania donovani | 90% | 100% |
| A4IAG5 | Leishmania infantum | 92% | 99% |